Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Onco-Innovations Limited

Onco-Innovations Limited (ONCO.NE) Stock Overview

Explore Onco-Innovations Limited’s financial performance, market position, analyst ratings, and future outlook.

ONCO.NE●NEO
HealthcareBiotechnology
$0.53
$0.03(5.36%)
Canadian Market opens in 14h 49m

Onco-Innovations Limited (ONCO.NE)

Meyka AI Score

Z

Key Financials

Market Cap31.6M
P/E RatioN/A
EPS (TTM)$-0.22
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$0.52
3 Months$0.25
1 Year TargetN/A

ONCO.NE Stock Analysis & Investment Overview (NEO)

Our AI-powered analysis of Onco-Innovations Limited (NEO: ONCO.NE) gives investors deep insight into how the stock performs on the NEO exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Onco-Innovations Limited's NEO-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ONCO.NE on the NEO shows an RSI of 36.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NEO listing.

Key metrics behind Onco-Innovations Limited's NEO-traded stock include a P/E ratio of N/A and a market capitalization of 31.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ONCO.NE on the NEO.

Price Performance (NEO: ONCO.NE)

1-Day Change
-5.36%
5-Day Change
-3.64%
1-Month Change
-24.29%
3-Month Change
-51.82%
6-Month Change
-22.06%
Year-to-Date (YTD) Change
-60.74%
1-Year Change
-71.81%
3-Year Change
-34.57%
5-Year Change
-34.57%
All-Time (Max) Change
-34.57%

Contact Information

https://oncoinnovations.com
NaN
7th Street SW, Calgary, AB, T2R 1M1

Company Facts

IPO DateDec 31, 2024
CountryCA
Actively Trading

Frequently Asked Questions